Centessa Pharmaceuticals Ownership | Who Owns Centessa Pharmaceuticals?
Centessa Pharmaceuticals Ownership Summary
Centessa Pharmaceuticals is owned by 93.86% institutional investors, 0.34% insiders, and 5.80% retail investors. Medicxi ventures management (jersey) is the largest institutional shareholder, holding 17.17% of CNTA shares. T. Rowe Price Health Sciences is the top mutual fund, with 2.40% of its assets in Centessa Pharmaceuticals shares.
CNTA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Centessa Pharmaceuticals | 93.86% | 0.34% | 5.80% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 19.96M | 17.17% | $334.38M |
| Index venture life associates vi | 9.96M | 8.57% | $166.86M |
| General atlantic | 9.68M | 8.33% | $162.17M |
| Perceptive advisors | 6.35M | 5.46% | $106.35M |
| First light asset management | 5.81M | 4.99% | $97.24M |
| Price t rowe associates inc /md/ | 5.36M | 4.61% | $89.85M |
| Adage capital partners gp | 5.12M | 4.40% | $85.74M |
| Janus henderson group | 4.91M | 4.22% | $82.22M |
| Fmr | 3.65M | 3.14% | $61.16M |
| Farallon capital management | 3.50M | 3.01% | $58.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Index venture life associates vi | 9.96M | 99.89% | $166.86M |
| Medicxi ventures management (jersey) | 19.96M | 63.20% | $334.38M |
| Foresite capital management vi | 1.25M | 9.35% | $20.99M |
| First light asset management | 5.81M | 9.30% | $97.24M |
| General atlantic | 9.68M | 5.77% | $162.17M |
| Octagon capital advisors lp | 1.99M | 5.49% | $33.38M |
| Allostery investments lp | 284.52K | 4.98% | $4.77M |
| Tcg crossover management | 2.89M | 4.73% | $48.42M |
| Ally bridge group (ny) | 244.54K | 3.51% | $4.10M |
| 5am venture management | 830.95K | 3.32% | $13.92M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Index venture life associates vi | 9.96M | 99.89% | 9.96M |
| Janus henderson group | 4.91M | 0.04% | 3.61M |
| Foresite capital management vi | 1.25M | 9.35% | 1.25M |
| Ubs group | 1.07M | 0.00% | 1.07M |
| Adage capital partners gp | 5.12M | 0.15% | 924.03K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vida ventures advisors | - | - | -3.93M |
| Ecor1 capital | - | - | -3.22M |
| Deep track capital, lp | - | - | -1.35M |
| Avidity partners management lp | 1.17M | 1.92% | -966.20K |
| Polar capital | - | - | -640.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Index venture life associates vi | 9.96M | 99.89% | 9.96M | $166.86M |
| Foresite capital management vi | 1.25M | 9.35% | 1.25M | $20.99M |
| Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main | 303.48K | 0.01% | 303.48K | $5.08M |
| Allostery investments lp | 284.52K | 4.98% | 284.52K | $4.77M |
| J. goldman & co lp | 164.70K | 0.07% | 164.70K | $2.76M |
Sold Out
| Holder | Change |
|---|---|
| Caldwell sutter capital | -43.00 |
| Bellevue asset management | -70.00 |
| Spire wealth management | -70.00 |
| Simplex trading | -108.00 |
| Nbc securities | -138.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 141 | 18.49% | 124,864,870 | 0.36% | 93 | 0.82% | 75 | 22.95% | 38 | - |
| Dec 31, 2024 | 118 | 11.32% | 124,412,240 | 14.59% | 107 | 1.23% | 60 | -21.05% | 38 | 137.50% |
| Sep 30, 2024 | 106 | 29.27% | 108,573,103 | 25.51% | 93 | 1.50% | 76 | 72.73% | 16 | -15.79% |
| Jun 30, 2024 | 81 | 14.08% | 86,506,233 | 16.28% | 86 | 1.45% | 44 | -6.38% | 18 | 260.00% |
| Mar 31, 2024 | 71 | 16.39% | 74,395,273 | 4.37% | 77 | 1.42% | 47 | 56.67% | 5 | -54.55% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 3.21M | 2.40% | -33.77K |
| Fidelity Select Biotechnology | 2.98M | 2.23% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.18M | 0.88% | - |
| Polar Capital Biotech S Inc | 1.00M | 0.75% | 33.35K |
| Janus Henderson Triton D | 965.19K | 0.72% | - |
| Janus Henderson US SMID Cap Growth | 953.94K | 0.71% | -11.25K |
| Janus Henderson US SMID Cap Growth MA | 953.94K | 0.71% | 953.86K |
| American Century U.S. Small Cap Growth | 888.01K | 0.66% | 33.57K |
| American Century Small Cap Growth Inv | 888.01K | 0.66% | 33.57K |
| Fidelity VIP Mid Cap Initial | 702.20K | 0.53% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 29, 2025 | Accardi Mario Alberto | President, Orexin Program | Sell | $126.75K |
| Jul 25, 2025 | Weinhoff Gregory M | Chief Business Officer | Sell | $155.60K |
| Jul 21, 2025 | SAHA SAURABH | Chief Executive Officer | Sell | $875.60K |
| Jul 15, 2025 | HUSSAIN IQBAL J | General Counsel | Sell | $89.57K |
| Jun 25, 2025 | Weinhoff Gregory M | Chief Business Officer | Sell | $138.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | 2 | 12 |
| 2025 Q1 | - | 18 |
| 2024 Q4 | - | 18 |
| 2024 Q3 | - | 11 |
CNTA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools